GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascletis Pharma Inc (HKSE:01672) » Definitions » Dividend-Payout-to-FFO

Ascletis Pharma (HKSE:01672) Dividend-Payout-to-FFO


View and export this data going back to 2018. Start your Free Trial

What is Ascletis Pharma Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Ascletis Pharma (HKSE:01672) Business Description

Traded in Other Exchanges
Address
198 Qidi Road, 12th Floor, Building D, HIPARK, Xiaoshan District, Zhejiang Province, Hangzhou, CHN, 311200
Ascletis Pharma Inc is an investment holding company engaged in the research and development, production, marketing, and sale of pharmaceutical products. It has three marketed products, i.e. ritonavir tablets, GANOVO, and ASCLEVIR. Geographically, it operates in Mainland China and other countries.